Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL.
D051722:ADAM Proteins / Q000502:physiology*; D000072198:ADAM17 Protein; D017209:Apoptosis / Q000187:drug effects; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology; D000077156:Gefitinib; D045325:HCT116 Cells; D019073:HT29 Cells; D006801:Humans; D045726:Metalloproteases / Q000502:physiology; D011799:Quinazolines / Q000494:pharmacology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000502:physiology; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis; D011994:Recombinant Proteins / Q000494:pharmacology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology*; D016211:Transforming Growth Factor alpha / Q000494:pharmacology / Q000502:physiology*; D019061:src-Family Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*
D051722:ADAM Proteins; D000072198:ADAM17 Protein; D066246:ErbB Receptors; D000077156:Gefitinib; D045726:Metalloproteases; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; D016211:Transforming Growth Factor alpha; D019061:src-Family Kinases; C105190:TNFRSF10A protein, human; C505653:TNFSF10 protein, human; C508053:ERBB2 protein, human; C000606462:ADAM17 protein, human